Rare Disease Therapeutics
Innovating in rare disease
We make a meaningful contribution to the lives of rare disease patients and their families
We champion accessibility to rare disease medicines
Championing access to rare disease medicines
Established Medicines
Helping more patients access established medicines
Innovative Medicines
Bringing innovative new medicines to patients in need
WHY ORANDA
Why Oranda
Founded on Partnership
Oranda is a company founded on partnership. We're entrepreneurial and agile, with a focus on delivering value to patients, our customers and partners.
The Oranda Fish
Our company is named after the Oranda, a special breed of goldfish symbolising longevity, adaptability, personal growth and the pursuit of fulfilment.
Beauty in Difference
It serves as a reminder that everyone is unique and can live positive and purposeful lives. Beauty lies in our differences.
WHAT WE DO
How We Create Access
Our Approach
We identify access gaps, act quickly with commercial partner agreements, and partner to deliver robust supply chains integrated into local healthcare systems.
Discover Our ApproachOur Focus
We are focused on identifying and addressing patient needs across therapy areas, currently commercialising in antifibrotic illnesses and Transthyretin Amyloid Cardiomyopathy.
Explore Our FocusCollaboration
Companies that partner with Oranda benefit from our commercial flexibility and resourceful ways of working. We're agile and can scale-up quickly.
Partner With UsWHAT PARTNERS SAY
Trusted by industry leaders
"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua."
Placeholder Company
"Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat."
Placeholder Company
"Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur excepteur sint."
Placeholder Company
"Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum."
Placeholder Company
"Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores."
Placeholder Company
FAQ
Common questions
Oranda's strategy is built on a dual-pillar approach: commercialising established rare disease medicines to improve patient access, and partnering to bring innovative new medicines to patients in need across Europe.
Oranda is currently focused on rare endocrinology and cardio-respiratory conditions, including hATTR, PAH, and CF.
Details of our funding rounds will be announced in due course.
We regularly attend industry conferences including BioEurope and Bio International Convention. Please see our Investors page for upcoming events.
Please complete a Contact form and we will be happy to discuss.
Ready to Partner?
Whether you're an investor, potential partner, healthcare professional, or journalist, we'd love to hear from you.
Get in Touch